Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E20.50 EPS (ttm)5.49 Insider Own0.02% Shs Outstand2.76B Perf Week-0.96%
Market Cap310.94B Forward P/E16.07 EPS next Y7.00 Insider Trans-25.54% Shs Float2.76B Perf Month3.21%
Income15.38B PEG3.73 EPS next Q1.68 Inst Own67.30% Short Float0.89% Perf Quarter10.78%
Sales70.18B P/S4.43 EPS this Y-3.90% Inst Trans0.06% Short Ratio2.90 Perf Half Y13.91%
Book/sh25.82 P/B4.36 EPS next Y6.30% ROA- Target Price114.58 Perf Year15.39%
Cash/sh- P/C- EPS next 5Y5.49% ROE- 52W Range80.61 - 114.19 Perf YTD10.30%
Dividend3.00 P/FCF- EPS past 5Y2.80% ROI16.90% 52W High-2.23% Beta0.59
Dividend %2.67% Quick Ratio- Sales past 5Y2.60% Gross Margin69.30% 52W Low38.50% ATR1.17
Employees127100 Current Ratio- Sales Q/Q0.60% Oper. Margin27.00% RSI (14)57.25 Volatility0.84% 1.07%
OptionableYes Debt/Eq- EPS Q/Q0.40% Profit Margin21.90% Rel Volume0.55 Prev Close112.48
ShortableYes LT Debt/Eq- EarningsApr 19 BMO Payout40.60% Avg Volume8.51M Price111.64
Recom2.40 SMA200.63% SMA502.94% SMA20011.20% Volume4,245,940 Change-0.75%
Apr-20-16Reiterated RBC Capital Mkts Outperform $122 → $125
Apr-20-16Reiterated Piper Jaffray Neutral $105 → $106
Apr-15-16Reiterated RBC Capital Mkts Outperform $114 → $122
Mar-14-16Upgrade Goldman Sell → Neutral
Dec-01-15Upgrade Barclays Equal Weight → Overweight $101 → $115
Oct-05-15Resumed Piper Jaffray Neutral $105
May-21-15Reiterated Deutsche Bank Hold $106 → $110
Dec-08-14Reiterated RBC Capital Mkts Outperform $110 → $114
Jul-16-14Reiterated Deutsche Bank Hold $102 → $107
Apr-17-14Reiterated Argus Buy $104 → $116
Apr-16-14Reiterated RBC Capital Mkts Outperform $104 → $106
Jan-10-14Downgrade Barclays Overweight → Equal Weight $99
Jan-07-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
Dec-16-13Reiterated Deutsche Bank Hold $93 → $95
Jul-18-13Reiterated Argus Buy $96 → $104
Jul-17-13Reiterated Barclays Overweight $95 → $99
Jul-17-13Downgrade Deutsche Bank Buy → Hold $92 → $93
Apr-18-13Reiterated Argus Buy $80 → $96
Apr-15-13Reiterated Barclays Overweight $85 → $95
Apr-12-13Reiterated Deutsche Bank Buy $82 → $87
Apr-29-16 02:05PM  Johnson & Johnsons 1Q16 Valuation Cheat Sheet Market Realist
11:12AM  Correction: Abbott-St Jude Acquisition story AP
09:42AM  Gilead Says European CHMP Adopts Positive Opinion For Its Odefsey For Treating HIV Benzinga
09:30AM  Zacks Investment Ideas feature highlights: Visa, Johnson & Johnson and Snap-On Incorporated Zacks
09:04AM  Drug Stocks Q1 Earnings Preview: AEGR, AERI, MACK, PRTA Zacks
Apr-28-16 11:28PM  Gilead Disappoints, Harvoni Sales Drop 16% Yahoo Finance Contributors
04:10PM  Will Johnson & Johnson (JNJ) Stock Be Helped by Dividend Hike? at TheStreet
03:00PM  AbbVie forges deeper into cancer, as clock ticks for Humira Reuters
01:48PM  Johnson & Johnson hikes dividend at shareholders meeting AP
12:23PM  Johnson & Johnson Boosts Dividend By 6.7% Benzinga
12:00PM  Biotech Boom May Continue Through Earnings Season Benzinga
10:44AM  Johnson & Johnson raises quarterly dividend to 80 cents vs. 75 cents at MarketWatch
10:30AM  Johnson & Johnson Announces Dividend Increase of 6.7% PR Newswire
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Novartis, Baxalta Incorporated and Shire Zacks
09:06AM  Johnson & Johnsons 1Q16 Profitability and 2016 Guidance Market Realist
08:05AM  Johnson & Johnsons 1Q16 Earnings: Major Developments Market Realist
07:00AM  Why Johnson & Johnson Is So Optimistic These Days at Motley Fool
Apr-27-16 06:26PM  This Is What Exxon Thinks Of Its S&P Debt Downgrade at Investor's Business Daily
09:05AM  There are only two companies left with top-notch AAA credit ratings Quartz
08:01AM  J&J's Q1 Results Suggest More Upside for Medivation, Inc. at Motley Fool
07:22AM  Exxon Mobils downgrade leaves just two AAA-rated companies in the U.S. at MarketWatch
12:08AM  [$$] Weak Dollar Gives a Lift to U.S. Earnings at The Wall Street Journal
Apr-26-16 07:49PM  Stung by low oil prices, Exxon loses 'AAA' rating from S&P AP
06:39PM  [$$] Weak Dollar Gives a Lift to U.S. Earnings at The Wall Street Journal
04:06PM  Johnson & Johnson Consumer Inc. to Acquire NeoStrata Company, Inc., a Leader in Dermocosmetics PR Newswire
03:28PM  Merck & Co.s 1Q16 Estimates Show Revenue Growth Market Realist
01:17PM  And then There Were Two: Exxon Loses Triple-A Rating at Barrons.com
12:50PM  [$$] S&P strips ExxonMobil of coveted triple A rating at Financial Times
10:00AM  4 Rock-Solid Dividend Stocks to Buy Regardless of Earnings Season Mania at TheStreet
09:51AM  Lilly (LLY) Raises View despite Q1 Earnings & Revenue Miss Zacks
08:53AM  Cramer's stocks to watch: Procter 'needs real growth' CNBC
07:24AM  Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One at TheStreet
07:16AM  Worried About Social Security? Buy These 4 Stocks at Motley Fool
Apr-25-16 08:06PM  A Segment-by-Segment Breakdown of JNJs 1Q16 Earnings Market Realist
04:04PM  Not a Great 1Q16 for VPMCX: Should You Worry? Market Realist
01:08PM  [$$] Big Food in health drive to keep market share at Financial Times
01:04PM  More Squawk From Jim Cramer: 'Aghast' at 'Terrible Way' That CEO Papa Left Perrigo (PRGO) at TheStreet
01:02PM  3 Data Points That Will Likely Define Amgen's First-Quarter Report on April 28 at Motley Fool
12:42PM  [$$] Depomed Says Starboard Has Month to Call Shareholder Meeting at The Wall Street Journal
Apr-24-16 07:13PM  [$$] Global health scares spur scientific innovation at Financial Times
07:12PM  [$$] Race for universal flu vaccine gathers pace at Financial Times
07:12PM  [$$] Experimental Ebola vaccines need testing at Financial Times
11:04AM  Competitors Take Aim at Intuitive Surgical, Inc. at Motley Fool
Apr-22-16 03:40PM  Procter & Gamble Just Issued Its Smallest Dividend Hike in a Generation -- Here's What it Means at Motley Fool
03:35PM  Johnson & Johnsons 1Q15 Earnings: Changes in Growth Rate Market Realist
03:35PM  Did Johnson & Johnsons 1Q16 See Earnings Growth? Market Realist
03:11PM  ETFs with exposure to Johnson & Johnson : April 22, 2016 at Capital Cube
12:17PM  Dow 30 Stock Roundup: IBM, AmEx, Coke, JNJ Beat, Verizon Disappoints Zacks
12:16PM  What Awaits Healthcare Stocks ESRX and EPZM in Q1 Earnings? Zacks
09:30AM  Zacks Investment Ideas feature highlights: Aflac, Johnson & Johnson, LKQ, Prestige Brands and Stryker Zacks
08:22AM  9 Things That Stand Out in Johnson & Johnson's Q1 Report at Motley Fool
Apr-21-16 04:43PM  Is TransEnterix Inc a "Bad News Buy"? at Motley Fool
12:16PM  Johnson & Johnson to Participate in the 2016 Deutsche Bank 41st Annual Health Care Conference PR Newswire
11:38AM  Johnson & Johnson :JNJ-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
Apr-20-16 06:36PM  Analysts: Johnson & Johnson Likely to Do Deal in Near Term at TheStreet
06:05PM  Xtandi: A Major Prostate Cancer Drug Market Realist
04:55PM  Apple PT Cut; Boeing Downgraded; Yahoo, J&J PTs Hiked at Investor's Business Daily
12:29PM  Why Biotech Will Benefit from Higher Drug Prices at Barrons.com
11:45AM  David-Goliath Fight Over Glucose Tests For Diabetics Hits Boiling Point at Forbes
10:28AM  [$$] H.I.G. Sells NeuWave Medical to Johnson & Johnson Business at The Wall Street Journal
10:13AM  Jim Cramer -- Abbott Labs Has 'Fantastic' Earnings, CEO at TheStreet
10:10AM  Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money at TheStreet
09:55AM  Healthcare ETFs to Buy on Blockbuster J&J Q1 Results Zacks
08:50AM  Top Analyst Upgrades and Downgrades: ArcelorMittal, Boeing, Intel, Schlumberger, Yahoo, Vivint Solar, Johnson & Johnson and More at 24/7 Wall St.
07:47AM  One and Done...and More! Yahoo Finance Contributors
06:30AM  4 Slow And Steady Blue Chips at Forbes
01:31AM  [$$] Johnson & Johnson Beats Expectations, Boosts Guidance at The Wall Street Journal
01:26AM  Genmab raises 2016 guidance on strong Darzalex sales Reuters
Apr-19-16 10:31PM  Asian stock indexes mixed; market focus on ECB remarks AP
07:36PM  Health Fund Shows Strength; Gold Sparkles But Silver Outshines
05:58PM  Final Trade: Bank of America, Intel, JPMorgan & more
05:48PM  Singled Out: Nasdaq Slips on Netflix Loss as Dow Flirts With Nine Month High at Barrons.com
05:15PM  Stocks End Mostly Higher; Earnings, Oil Eyed
04:43PM  Dow gains foothold above 18,000; IBM drags on tech sector at MarketWatch
04:28PM  US STOCKS-Wall Street nears record as quarterly reports roll in Reuters
04:23PM  IBM, J&J, Other Giants See Dollar Impact On Earnings, Sales Fading
04:20PM  Intuitive Surgical Beats Q1 Estimates As Stock Hovers Near High
04:03PM  Energy and Tech Duke It Out as Stocks End Mixed at TheStreet
04:00PM  What's Next for Stocks? Look at Fiscal Flows for Guidance
03:41PM  Jim Cramer -- Johnson & Johnson Is a Standout Among Drug Stocks at TheStreet
03:07PM  Johnson & Johnson Boosts Guidance on Strong 1st-Quarter Results at Motley Fool
03:00PM  Johnson & Johnson Doesn't Need a Band-Aid
02:57PM  Johnson & Johnson's Slow-Motion Shift at Bloomberg
02:55PM  US STOCKS-Wall St nears record terrain as quarterly reports roll in Reuters
02:44PM  Johnson & Johnson Surges Into New All-Time-High Territory at TheStreet
02:11PM  Cramer: This stock has 'mojo' at CNBC
01:00PM  Johnson & Johnson rides strong prescription sales in 1Q
01:00PM  Are Johnson & Johnson's Earnings Estimates Too Healthy? (JNJ) at Investopedia
12:54PM  Why Johnson & Johnson's Earnings are Good News for Big Biotech at Barrons.com
12:27PM  J&J shares hit new high on strong drug sales, weaker dollar
12:03PM  Jim Cramer -- Skip GlaxoSmithKline, but Buy Johnson & Johnson at TheStreet
12:00PM  [$$] Johnson & Johnson Beats Expectations, Boosts Guidance at The Wall Street Journal
12:00PM  Stocks Mostly Higher; Earnings, Oil Eyed
11:45AM  Jim Cramer Likes Johnson & Johnson, Allergan in the Pharma Sector at TheStreet
11:11AM  [$$] JNJ Eyes Changes in Contact Lens at Barrons.com
11:01AM  Why Are These 5 Stocks in the Spotlight Today? at Insider Monkey
11:01AM  Johnson & Johnson shares rise on higher Q1 results at USA TODAY
11:00AM  J&J Ebola Vaccine Has Promise as Wider Test Awaits Next Outbreak at Bloomberg
10:41AM  J&J Earnings Beat Estimates; Guidance Raised As FX Headwinds Ease
10:24AM  Dow, S&P 500 Rise As Nasdaq Slips; UnitedHealth, New Oriental Climb
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women's health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Caruso Dominic JVP, Finance; CFOFeb 08Option Exercise0.0029,0050125,466Feb 10 06:02 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0067,9330197,441Feb 10 06:02 PM
PETERSON SANDRA EGroup Worldwide ChairmanFeb 08Option Exercise0.007,633037,943Feb 10 06:03 PM
Fasolo PeterVP, Global Human ResourcesFeb 08Option Exercise0.0018,777056,512Feb 10 06:03 PM
Ullmann Michael HVP, General CounselFeb 08Option Exercise0.0016,697098,071Feb 10 06:03 PM
Stoffels PaulusChief Scientific OfficerFeb 08Option Exercise0.0028,2420131,104Feb 10 06:03 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,598026,023Feb 10 06:03 PM
Fasolo PeterVP, Global Human ResourcesFeb 03Option Exercise72.54144,56810,486,963182,303Feb 04 06:04 PM
Fasolo PeterVP, Global Human ResourcesFeb 03Sale104.12144,56815,052,42037,735Feb 04 06:04 PM
Fasolo PeterVP, Global Human ResourcesFeb 02Option Exercise72.546,817494,50544,552Feb 04 06:04 PM
Fasolo PeterVP, Global Human ResourcesFeb 02Sale104.096,817709,58837,735Feb 04 06:04 PM
Caruso Dominic JVP, Finance; CFOJan 15Option Exercise0.0011,6020100,336Jan 20 07:25 PM
Fasolo PeterVP, Global Human ResourcesJan 15Option Exercise0.007,511040,578Jan 20 07:25 PM
Gorsky AlexChairman, CEOJan 15Option Exercise0.0027,1730140,534Jan 20 07:25 PM
PETERSON SANDRA EGroup Worldwide ChairmanJan 15Option Exercise0.003,053031,616Jan 20 07:25 PM
Ullmann Michael HVP, General CounselJan 15Option Exercise0.006,679083,907Jan 20 07:25 PM
Kapusta Ronald AController, CAOJan 15Option Exercise0.003,896024,699Jan 20 07:25 PM
Stoffels PaulusChief Scientific OfficerJan 15Option Exercise0.0011,2970106,585Jan 20 07:25 PM
PETERSON SANDRA EGroup Worldwide ChairmanDec 17Option Exercise0.0021,688040,730Dec 21 05:09 PM
Ullmann Michael HVP, General CounselNov 20Option Exercise58.3422,6261,320,00194,878Nov 24 01:00 PM
Ullmann Michael HVP, General CounselNov 20Sale102.4717,6501,808,54377,228Nov 24 01:00 PM
Caruso Dominic JVP, Finance; CFONov 02Option Exercise58.3420,5691,199,995109,303Nov 04 05:05 PM
Caruso Dominic JVP, Finance; CFONov 02Sale102.2120,5692,102,42388,734Nov 04 05:05 PM
Kapusta Ronald AController, CAOOct 23Option Exercise58.346,239363,98327,042Oct 27 03:38 PM
Kapusta Ronald AController, CAOOct 23Sale99.686,239621,90420,803Oct 27 03:38 PM
PRINCE CHARLESDirectorAug 06Buy99.252,500248,13225,645Aug 10 12:49 PM
PRINCE CHARLESDirectorJun 02Buy99.222,500248,05023,145Jun 03 05:20 PM